Relevant bibliographies by topics / Advanced vulvar carcinoma

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Advanced vulvar carcinoma'

Author: Grafiati
Published: 3 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Advanced vulvar carcinoma.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Advanced vulvar carcinoma"

1

Rogers, Linda J. "Management of Advanced Squamous Cell Carcinoma of the Vulva." Cancers 14, no. 1 (2021): 167. http://dx.doi.org/10.3390/cancers14010167.

Full text
Abstract:
Vulvar cancer is a rare gynaecological malignancy, accounting for 2–5% of cancers of the female genital tract. Squamous cell carcinoma is the most frequently occurring subtype and, historically, has been a disease of older post-menopausal women, occurring with a background of lichen sclerosus and other epithelial conditions of the vulvar skin that may be associated with well-differentiated vulvar intra-epithelial neoplasia (dVIN). An increase in human papillomavirus (HPV) infections worldwide has led to an increase in vulvar squamous carcinomas in younger women, resulting from HPV-associated h
APA, Harvard, Vancouver, ISO, and other styles
2

Viktora, Libor, Luboš Minář, Michal Felsinger, and Vít Weinberger. "Vulvar carcinoma and its recurrences – principles of surgical treatment." Česká gynekologie 87, no. 6 (2022): 401–7. http://dx.doi.org/10.48095/cccg2022401.

Full text
Abstract:
Objective: A comprehensive overview of the surgical treatment of vulvar cancer, including recurrent forms. Methodology: A review work providing a basic overview of the pathogenesis, dia gnosis and surgical treatment of vulvar cancer with a focus on the possibilities of treatment of its recurrences. It includes an illustrative case report presenting a patient with invasive squamous cell carcinoma of the vulva with iterative local recurrences and subsequent development of tumor triplicity and distant metastatic involvement. Conclusion: Surgical treatment remains the main modality of vulvar cance
APA, Harvard, Vancouver, ISO, and other styles
3

Pinn, Melva, Laura Austin, David Schomas, and Robert Miller. "Case report from Mayo Clinic: Locally advanced Bartholin gland carcinoma." Radiology and Oncology 41, no. 2 (2007): 72–79. http://dx.doi.org/10.2478/v10019-007-0013-x.

Full text
Abstract:
Case report from Mayo Clinic: Locally advanced Bartholin gland carcinoma Tumors of the Bartholin gland are rare, comprising less than 5% of all vulvar malignancies. Treatment is largely based on that of vulvar and anal squamous cell carcinomas. A case of invasive, grade 4, poorly differentiated squamous cell carcinoma of the Bartholin gland is presented. Our patient, a 47-year-old woman, had a history significant for cervical intraepithelial neoplasia treated with conization, type 2 diabetes mellitus, and tobacco use. The course of treatment included preoperative radiotherapy plus 5-fluorourac
APA, Harvard, Vancouver, ISO, and other styles
4

Chávez Nava, Myriam, Julio César González Rodríguez, Eder Alexandro Arango Bravo, et al. "Oncoguía de cáncer de vulva 2023." Latin american journal of clinical sciences and medical technology 5, no. 1 (2023): 231–42. http://dx.doi.org/10.34141/ljcs6010447.

Full text
Abstract:
Vulvar cancer is a rare neoplasm. Risk factors for the development of vulvar cancer include advanced age, human papillomavirus infection leading to high-grade squamous intraepithelial lesions, smoking, inflammatory conditions affecting the vulva, immunodeficiencies such as human immunodeficiency virus infection, and the presence of well-differentiated vulvar intraepithelial neoplasia (VIN) in patients from 65 to 70 years. VIN may be asymptomatic or present with a mixed variety of symptoms, including itching, discomfort, burning, pain during sexual intercourse, and whitish spots over the vulva.
APA, Harvard, Vancouver, ISO, and other styles
5

Musella, Angela, Claudia Marchetti, Laura Salerno, et al. "An Unexpected Complete Remission of Advanced Intestinal-Type Vulvar Adenocarcinoma after Neoadjuvant Chemotherapy: A Case Report and a Literature Review." Case Reports in Obstetrics and Gynecology 2013 (2013): 1–5. http://dx.doi.org/10.1155/2013/427141.

Full text
Abstract:
Vulvar cancer represents approximately 3%–5% of all gynecological malignancies. Squamous cell carcinoma is the most frequent histotype, whereas melanomas, adenocarcinomas, basal cell carcinomas, and sarcomas are much less common. Intestinal-type adenocarcinoma is a rare variant of vulvar carcinoma with only few cases found in the literature. The origin of this neoplasia is still much debated, but the most reliable hypothesis is the origin from cloacal remnants that may persist in the adult in different organs. Because of its extremely low incidence, the optimal management of this kind of vulva
APA, Harvard, Vancouver, ISO, and other styles
6

Verma, Pallavi, Sushil Chawla, Sandhyarani -, Sunil Anand, Rahul Mahajan, and Divya Shelly. "Squamous Cell Carcinoma Bartholin’s Gland: Management Challenges: Case Report and Review of Literature." Asian Pacific Journal of Cancer Care 10, no. 2 (2025): 653–56. https://doi.org/10.31557/apjcc.2025.10.2.653-656.

Full text
Abstract:
Bartholin gland carcinoma is an unusual malignancy, accounting for less than 5% of all vulval cancers. Squamous cell carcinoma is the most common histological type, followed by adenocarcinoma. Bartholin’s gland carcinomas develop into masses of varying sizes and may be ulcerated or deep to the surface with the overlying skin intact. Because little is known about bartholin’s gland cancer, it is frequently misdiagnosed as an abscess or a cyst. Diagnosis is often delayed until discovered at advanced stages. To add to the literature, we report a case of locally advanced stage bartholin’s gland car
APA, Harvard, Vancouver, ISO, and other styles
7

Krynicki, Ryszard, Agnieszka Nalewczyńska, Bogusław Lindner, Magdalena Kowalska, and Beata Śpiewankiewicz. "Neoadjuvant chemoradiotherapy in advanced vulvar carcinoma." Current Gynecologic Oncology 14, no. 2 (2016): 89–96. http://dx.doi.org/10.15557/cgo.2016.0010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Bhalwal, Asha B., Alpa M. Nick, Ricardo dos Reis, et al. "Carcinoma of the Bartholin Gland: A Review of 33 Cases." International Journal of Gynecologic Cancer 26, no. 4 (2016): 785–89. http://dx.doi.org/10.1097/igc.0000000000000656.

Full text
Abstract:
ObjectivePrimary carcinoma of the Bartholin gland is a rare malignancy that accounts for approximately 5% of vulvar carcinomas. The aim of the study was to compare the outcomes of women with primary Bartholin gland carcinoma (BGC) with those with non-Bartholin gland–related vulvar carcinoma.Materials and MethodsA retrospective chart review of 429 patients with invasive vulvar carcinoma evaluated at a single institution between 1993 and 2011 was performed. Medical records were reviewed for demographic data, pathologic information, treatment type, and recurrence/outcome information. These variab
APA, Harvard, Vancouver, ISO, and other styles
9

Banner-Voigt, Marie Louise Vorndran Coeln, Hanne From Mathiesen, Soeren Lassen, and Mansoor Raza Mirza. "Definitive image guided (IGRT) intensity-modulated arc radiotherapy (arctherapy) for locally advanced squamous cell carcinoma of the vulva." Journal of Clinical Oncology 31, no. 15_suppl (2013): e16540-e16540. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e16540.

Full text
Abstract:
e16540 Background: To determine early clinical outcome of PET-CT image guided intensity modulated arc radiotherapy with concomitant weekly cisplatin as definitive treatment of locally advanced or loco-regional unresectable relapsed vulvar cancer. Methods: Primary or relapsed (after surgery) patients (pts) with locally or loco-regionally advanced vulvar cancer not amenable to surgery were treated with radiation (RT) plus weekly cisplatin. All pts were planed by PET-CT scan. The decision to irradiate vulva and/or unilateral/bilateral nodes was made independently. Vulva was irradiated if macrosco
APA, Harvard, Vancouver, ISO, and other styles
10

Stana, Mihaela Mărioara, Sandra Deac, and Călin Cainap. "What to do when nothing else is left to be done - metastatic non-HPV vulvar squamous cell carcinoma with multiple lines of chemotherapy." Archive of Clinical Cases 8, no. 3 (2021): 50–55. http://dx.doi.org/10.22551/2021.32.0803.10186.

Full text
Abstract:
Recurrent vulvar squamous cell carcinoma with multiple site metastases is a rare entity – (up to 14.2% of the total number of recurrences), with a poor prognosis (only 15% of the patients alive at 5 years). Due to its “hard to find” character, there are no standardized guidelines available and the treatment is extrapolated from advanced cervical carcinoma, anal carcinoma and other squamous cell carcinomas. Immunotherapy has shown some positive results in vulvar carcinoma with PD-L1 positive, high TMB, high MSI or with MMR deficiency. An alternative for selected cases without therapeutic resour
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Advanced vulvar carcinoma"

1

Rogers, Linda Joy. "Chemoradiation in advanced vulval carcinoma." Master's thesis, University of Cape Town, 2008. http://hdl.handle.net/11427/3054.

Full text
Abstract:
Includes abstract.<br>Includes bibliographical references (leaves 68-74).<br>Vulval carcinoma is uncommon, affecting approximately 2 per 100 000 women annually. The treatment of choice is radical vulvectomy and inguinal lymph node dissection. ‘Advanced’ vulval carcinomas involve midline structures (such as clitoris, urethra or anus) and/or adjacent pelvic organs or bone, and adequate excision may require urinary diversion, colostomy or pelvic exenteration. Less morbid and less mutilating therapeutic alternatives have been investigated, particularly chemoradiation, which has shown significant s
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Advanced vulvar carcinoma"

1

Hoskin, Peter. Vulva and vagina. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199696567.003.0014.

Full text
Abstract:
Chapter 9b discusses carcinoma of the vulva, which is primarily a surgical disease best treated by wide surgical resection, radical vulvectomy, and inguinal lymph node dissection based on presenting stage. Rarely, locally advanced primary disease may be presented for primary radiotherapy treatment. Postoperative radiotherapy is recommended for tumours invading &gt;7 mm in a vertical direction. The first station regional lymph nodes in the inguinal region are best treated by radical surgical dissection, but fixed inoperable lymph nodes may benefit from primary radiotherapy which may be followed
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Advanced vulvar carcinoma"

1

Hoskin, Peter. "Perineal Implants: Anal Canal, Vagina, And Vulva." In Radiotherapy in practice: brachytherapy. Oxford University PressOxford, 2005. http://dx.doi.org/10.1093/oso/9780198529408.003.0008.

Full text
Abstract:
Abstract Perineal tumours are typically squamous cell carcinomas readily accessible to interstitial or intralumenal brachytherapy. Brachytherapy should be considered in the radical radiotherapeutic management of these sites and it may also have an important role for the palliation of locally advanced or recurrent disease.
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Advanced vulvar carcinoma"

1

Singh, Nisha. "Cohort study of vulvar cancer cases over a period of 10 years." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685356.

Full text
Abstract:
Objective: To study the risk factors, management protocols and outcome of vulvar cancer cases over a period of 10 years in a tertiary care hospital. Methods: It is a retrospective cohort study of vulvar cancer from January 2004 to January 2014 at King George Medical University, Lucknow. Hospital records of 41 patients with histologically proven diagnosis of vulvar cancer were studied from Department of Obstetrics and Gynecology and Department of Radiotherapy. The presence of risk factors, stage of disease, treatment modalities used and disease outcome in terms survival were studied. The data c
APA, Harvard, Vancouver, ISO, and other styles
2

Abuhijla, F., R. Abuhijlih, S. Salah, et al. "490 Predictive value of pre-treatment hematological parameters to definitive chemoradiation response in locally advanced vulvar carcinoma." In ESGO 2021 Congress. BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/ijgc-2021-esgo.623.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Adorni, M., S. Negri, L. Bazzurini, et al. "449 Role of neoadjuvant chemotherapy on local control in locally advanced vulvar carcinoma: a single institution experience." In IGCS 2020 Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2020. http://dx.doi.org/10.1136/ijgc-2020-igcs.390.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

"Vulvar cancer: Patterns of recurrence and clinicopathological prognostic factors involved in recurrent cases." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685347.

Full text
Abstract:
Objective: Vulvar cancer is a rare disease, with an incidence of 0.6% of all female malignancies. With the advances in management of carcinoma vulva to individualisation of treatment to reduce the psychosexual impact an aggressive treatment can have, it is imperative to understand the patterns of recurrence and the common prognostic factors involved. The aim of this study was to determine prognostic variables for recurrence and survival and to identify patterns of recurrence in patients with vulvar cancer. Materials and Methods: All patients (n=87) with primary vulvar cancer treated at the Raj
APA, Harvard, Vancouver, ISO, and other styles
5

Rosazza Zamora, Percy Teobaldo. "#459 Locally advanced vulvary carcinoma: what is the best treatment option?" In ESGO 2023 Congress. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/ijgc-2023-esgo.461.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Advanced vulvar carcinoma' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography